News

Novo Nordisk rode Ozempic’s success to becoming Europe’s top company. Now it’s faltering and its CEO is out.
Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...
pharmaphorum3d
Novo Nordisk CEO agrees to testify on semaglutide pricing
Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing. President Donald Trump said ...
Novo Nordisk CEO to step down amid market challenges
Novo Nordisk (NVO) stock falls as the company CEO Lars Fruergaard Jørgensen steps down after 8 years of leadership marked by ...
Reuters4d
Novo Nordisk A/S
Novo Nordisk should look to the US for its next CEO, analysts say As Denmark's Novo ... note on Monday after the United States and China agreed to temporarily slash tariffs, providing some ...
Yahoo Finance12d
Why Novo Nordisk missed its sales estimates on weight-loss drug Wegovy: CEO
Novo Nordisk's (NVO) investors are worried its competition ... according to the latest prescription data last month. But Novo CEO Lars Jørgensen attributes the softness in sales to the ...